We are live on ! Find out more
HIMS icon

Hims & Hers Health

197 hedge funds and large institutions have $1.12B invested in Hims & Hers Health in 2023 Q4 according to their latest regulatory filings, with 38 funds opening new positions, 71 increasing their positions, 57 reducing their positions, and 29 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more capital invested

Capital invested by funds: $749M → $1.12B (+$373M)

31% more first-time investments, than exits

New positions opened: 38 | Existing positions closed: 29

25% more repeat investments, than reductions

Existing positions increased: 71 | Existing positions reduced: 57

22% more call options, than puts

Call options by funds: $13.8M | Put options by funds: $11.4M

3.16% more ownership

Funds ownership: 58.74%61.9% (+3.2%)

3% more funds holding

Funds holding: 191197 (+6)

14% less funds holding in top 10

Funds holding in top 10: 76 (-1)

Holders
197
Holders Change
+6
Holders Change %
+3.14%
% of All Funds
2.87%
Holding in Top 10
6
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-14.29%
% of All Funds
0.09%
New
38
Increased
71
Reduced
57
Closed
29
Calls
$13.8M
Puts
$11.4M
Net Calls
+$2.46M
Net Calls Change
+$2.12M
Name Holding Trade Value Shares
Change
Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$126M +$344K +46,541 +0.3%
BlackRock
2
BlackRock
New York
$96.6M +$3.8M +513,698 +5%
FVM
3
Forerunner Ventures Management
California
$86.8M +$72.1M +9,756,893 New
IVMX
4
Institutional Venture Management XVI
California
$68.7M
IVMX
5
Institutional Venture Management XV
California
$68.7M
RM
6
Redpoint Management
California
$67.4M
Marshall Wace
7
Marshall Wace
United Kingdom
$46.9M -$6.7M -906,207 -15%
NCPI
8
NewView Capital Partners I
California
$35M
FCMV
9
Foresite Capital Management V
California
$34.1M +$739K +100,000 +3%
N
10
Nuveen
North Carolina
$31.6M +$3.13M +423,251 +14%
BC
11
BIT Capital
Germany
$31.4M -$23.1M -3,121,054 -47%
State Street
12
State Street
Massachusetts
$27.8M -$362K -49,019 -2%
Bank of America
13
Bank of America
North Carolina
$25.8M +$19.2M +2,600,222 +869%
Geode Capital Management
14
Geode Capital Management
Massachusetts
$25.3M +$1.03M +139,084 +5%
Morgan Stanley
15
Morgan Stanley
New York
$21.8M +$7.15M +967,195 +65%
Dimensional Fund Advisors
16
Dimensional Fund Advisors
Texas
$19.1M +$1.43M +193,507 +10%
Millennium Management
17
Millennium Management
New York
$18.3M +$5.55M +751,208 +58%
Citadel Advisors
18
Citadel Advisors
Florida
$17.7M +$6.66M +900,307 +83%
Franklin Resources
19
Franklin Resources
California
$16.1M +$32.2K +4,350 +0.2%
Charles Schwab
20
Charles Schwab
California
$11.5M +$163K +22,009 +2%
CSS
21
Cubist Systematic Strategies
Connecticut
$11.1M -$2.21M -299,046 -19%
Goldman Sachs
22
Goldman Sachs
New York
$10.9M -$9.1M -1,230,601 -50%
AllianceBernstein
23
AllianceBernstein
Tennessee
$10.7M -$2.24M -302,642 -20%
JAM
24
Jupiter Asset Management
United Kingdom
$10.7M -$1.88M -254,341 -17%
Northern Trust
25
Northern Trust
Illinois
$10.5M +$164K +22,151 +2%

HIMS Hedge Fund Activity: Q4 2023 in Review

197 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Hims & Hers Health (HIMS) for Q4 2023, worth a combined $1.12B — up 50% from $749M a quarter earlier.

Buyers outnumbered sellers: 38 funds opened new HIMS positions and 29 closed out — a net gain of 9 holders — while 71 added to existing stakes and 57 trimmed.

The largest buyer was Bank of America, adding an estimated $19.2M. The largest seller was BIT Capital, cutting an estimated $23.1M.

  • 197 institutional investors held Hims & Hers Health (HIMS) as of Q4 2023, up from 191 in Q3 2023.
  • Funds reported $1.12B of Hims & Hers Health stock for Q4 2023, up 50% quarter-over-quarter.
  • 38 funds opened new Hims & Hers Health positions in Q4 2023 and 29 closed out, a net change of +9 holders.
  • The largest Hims & Hers Health buyer in Q4 2023 was Bank of America, an estimated $19.2M added.
  • The largest Hims & Hers Health seller in Q4 2023 was BIT Capital, an estimated $23.1M sold.

Based on aggregated 13F filings for Q4 2023.